NevadaNano Systems, Inc. Brings Innovative Molecular Property Spectrometer™ Sensor Technology for Gas Leak Detection to EMEA
29.9.2020 09:00:00 EEST | Business Wire | Press release
NevadaNano Systems, Inc., the world’s leading innovator in gas detection sensor technology, announced a significant investment in Europe, the Middle East, and Africa (EMEA), with new operations in the UK and a distribution partnership with UNITRONIC GmbH. Gary Collins, general manager, EMEA, will lead the company’s expansion from the office outside Chester, England. NevadaNano’s patented Molecular Property Spectrometer™ measures and classifies a wide range of combustible gases and reports the potential to cause harm in a matter of seconds.
“NevadaNano’s innovative gas leak detection technology has the potential to save lives and create healthier environments better than any legacy technology,” said Gary Collins, general manager, EMEA for NevadaNano Systems. “I am delighted to join the team and bring its groundbreaking technology to business and industry throughout EMEA.”
UNITRONIC, will represent NevadaNano in Germany, Switzerland, and Austria. “NevadaNano brings important new technology that meets a growing need among our current customers and a wide range of companies in the areas we serve,” said Eduard Schäfer, senior product manager sensors at UNITRONIC. “We look forward to a long and successful relationship.”
NevadaNano’s patented Molecular Property Spectrometer™ (MPS) is the only technology available that measures and classifies a wide range of combustible gases and reports the potential to cause harm virtually instantaneously. It is the first new gas sensing technology to emerge in more than three decades and helps businesses create safer work, home and industrial environments. NevadaNano focuses on commercial applications, specifically, monitoring for flammable gas, new refrigerant leaks, methane leaks and indoor air quality. All of these applications are often tied together as part of IoT-enabled distributed gas sensing systems. The company technology is used in a diverse array of commercial and government applications by its system integrator partners and manufacturers.
MPS was developed at the University of Nevada, Reno, and supported by DARPA, the DOD, and the Department of Homeland Security. NevadaNano holds exclusive licenses for 43 inventions and 24 patents for on-chip chemical analysis technology. For information visit NevadaNano.com or connect on Linkedin.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200928005568/en/
Contact information
Phyllis Grabot - 805.341.7269, phyllis@corridorcomms.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
L&T Technology Services Launches Ainfonix ™ 4.0 to Unlock Engineering Intelligence Across Process Industries30.6.2026 13:45:00 EEST | Press release
L&T Technology Services (BSE: 540115, NSE: LTTS), a global leader in Engineering Intelligence Solutions & ER&D Consulting Services, today announced the launch of Ainfonix™ 4.0, a next-generation Engineering Intelligence platform for process industries. Unveiled at EI Live, LTTS’ flagship event that brings together analysts, industry leaders and engineering experts, Ainfonix™ 4.0 marks an important step in the company’s Enterprise AI and Engineering Intelligence strategy. As industrial enterprises accelerate AI adoption, decades of engineering knowledge remain trapped in fragmented drawings, specifications and technical records across disparate systems. Without trusted and accessible engineering data, organizations struggle to realize the full value of AI, automation and digital transformation initiatives. Ainfonix™ 4.0, developed in LTTS’ Sustainability segment, addresses this challenge by transforming engineering artifacts and multi-modal data into structured, asset-linked information
Klick Health Acquires Oxford PharmaGenesis, Bringing Together Unsurpassed Scientific-to-Commercial Capabilities for Life Sciences Clients30.6.2026 13:03:00 EEST | Press release
Focused on taking life sciences companies into the future, Klick Health today announced its acquisition of Oxford PharmaGenesis, the market-leading HealthScience communications consultancy renowned for its scientific and medical expertise, as well as value and market access consulting throughout Europe, Asia-Pacific, and North America. Today’s news brings together two of the leading independent agencies in life sciences. With Oxford PharmaGenesis’ expertise across medical affairs and market access, and Klick's strength in commercial strategy, medical, creative, digital, analytics, and experience design, they can deliver an unparalleled scientific-to-commercial experience. “We are beyond proud to join forces with Chris, Richard, and the entire team at Oxford PharmaGenesis as we focus on helping life sciences clients think holistically about how evidence, medical strategy, access considerations, and stakeholder engagement connect across the lifecycle with a scientific-to-commercial offer
BeOne Medicines Announces Positive Phase 3 Results for BRUKINSA in Frontline Mantle Cell Lymphoma30.6.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the Phase 3 MANGROVE study (BGB-3111-306; NCT04002297) evaluating foundational BTK inhibitor BRUKINSA® (zanubrutinib) plus rituximab versus bendamustine plus rituximab (BR) in adult patients with previously untreated mantle cell lymphoma (MCL). MANGROVE is the first Phase 3, global, randomized trial to evaluate a BTK inhibitor-based chemotherapy-free regimen against standard chemoimmunotherapy in this setting. This pivotal Phase 3 trial builds on the established clinical evidence for BRUKINSA in MCL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “For patients with newly diagnosed MCL, chemotherapy is currently the default. MANGROVE demonstrates for the first time that BRUKINSA plus rituximab, a chemotherapy-free regimen, can deliver unprecedented improvements in progression-free survival, potentially redefining the
Hytera Debuts SC700 Smart 4G Body Camera at CCW 202630.6.2026 12:30:00 EEST | Press release
Hytera, a leading global provider of critical communications technologies and solutions, officially debuted its SC700 Smart 4G Body Camera at Critical Communications World (CCW) 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630283236/en/ Hytera's latest SC700 Smart 4G Body Camera Public safety operations are increasingly moving toward real-time, connected workflows, where communication, video, and situational awareness are integrated to support a faster and more coordinated response in the field. The SC700 is designed to support this shift. It enables live video, location sharing and push-to-talk communication, helping connect frontline officers with control rooms. Integrated with Hytera HyTalk PoC System, it also supports communication across broadband and PMR users to improve coordination across teams. It also features Intelligent Scene Aware, which can detect abnormal situations such as man down, inactivity, or
Global Database Launches Regis, an AI Assistant for Live Company Registry Data30.6.2026 12:13:00 EEST | Press release
Global Database today announced the launch of Regis, a new AI assistant designed to answer business questions using live company data from official government registries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630229011/en/ Unlike general-purpose AI tools that rely on training data or open web sources, Regis is connected to Global Database’s structured company intelligence platform, covering more than 600 million company profiles, sourced from over 400 government registries across more than 200 countries. For more than a decade, Global Database has been collecting, structuring, and maintaining company data directly from government registries around the world. With the launch of Regis, the company is now presenting that information in a new way: through a conversational AI assistant that allows users to ask business questions in plain English and receive structured, source-backed answers. Regis allows users to ask
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
